These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 14551520)

  • 21. Aggressive statin therapy in multicenter and effectiveness for the reduction of intra-myocardial damage caused by non-ST elevation acute coronary syndrome: AMERICA study.
    Hara H; Nakamura M; Yokouchi I; Kimura K; Nemoto N; Ito S; Ono T; Itaya H; Shiba M; Wada M; Iijima R; Yamamoto M; Yamamoto M; Hara H; Takagi T; Asahara T; Mitsuo K; Kobayashi N; Sugi K
    Ther Adv Cardiovasc Dis; 2009 Oct; 3(5):357-65. PubMed ID: 19638365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Direct coronary stenting versus stenting with balloon pre-dilation: incidence of enzyme release and follow-up results of a multicentre, prospective, randomized study. The CK and Troponin I Estimation in direct STenting (CK TEST) trial.
    Balducelli M; Varani E; Vecchi G; Paloscia L; Manari A; Santarelli A; Cappi B; Shoeib A; Valenti S; Maresta A;
    Minerva Cardioangiol; 2007 Jun; 55(3):281-9. PubMed ID: 17534246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of B-type natriuretic peptide in addition to troponin I, creatine kinase-MB, and myoglobin on the risk stratification of emergency department chest pain patients with potential acute coronary syndrome.
    Brown AM; Sease KL; Robey JL; Shofer FS; Hollander JE
    Ann Emerg Med; 2007 Feb; 49(2):153-63. PubMed ID: 17084941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic significance of creatine kinase release after percutaneous coronary intervention.
    Cavallini C; Rugolotto M; Savonitto S
    Ital Heart J; 2005 Jun; 6(6):522-9. PubMed ID: 16008158
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic importance of troponin T and creatine kinase after elective angioplasty.
    Nienhuis MB; Ottervanger JP; Dikkeschei B; Suryapranata H; de Boer MJ; Dambrink JH; Hoorntje JC; van 't Hof AW; Gosselink M; Zijlstra F
    Int J Cardiol; 2007 Aug; 120(2):242-7. PubMed ID: 17182137
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Troponins in acute coronary syndromes.
    Scirica BM; Morrow DA
    Semin Vasc Med; 2003 Nov; 3(4):363-74. PubMed ID: 15199443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Troponin elevation after percutaneous coronary intervention directly represents the extent of irreversible myocardial injury: insights from cardiovascular magnetic resonance imaging.
    Selvanayagam JB; Porto I; Channon K; Petersen SE; Francis JM; Neubauer S; Banning AP
    Circulation; 2005 Mar; 111(8):1027-32. PubMed ID: 15723982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes.
    Roe MT; Mahaffey KW; Kilaru R; Alexander JH; Akkerhuis KM; Simoons ML; Harrington RA; Tardiff BE; Granger CB; Ohman EM; Moliterno DJ; Lincoff AM; Armstrong PW; Van de Werf F; Califf RM; Topol EJ
    Eur Heart J; 2004 Feb; 25(4):313-21. PubMed ID: 14984920
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of statin therapy on coronary intervention for non-ST elevation acute coronary syndrome with decreased low-density lipoprotein cholesterol.
    Hara H; Nakamura M; Yokouchi I; Kimura K; Nemoto N; Ito S; Ono T; Shiba M; Wada M; Tsuji T; Komatsu H; Iijima R; Nakajima R; Yamamoto M; Yamamoto M; Yoshitama T; Takagi T; Hara H; Sugi K
    J Cardiol; 2007 Mar; 49(3):115-23. PubMed ID: 17444137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discordant cardiac biomarkers: frequency and outcomes in emergency department patients with chest pain.
    Storrow AB; Lindsell CJ; Han JH; Slovis CM; Miller KF; Gibler WB; Hoekstra JW; Peacock WF; Hollander JE; Pollack CV;
    Ann Emerg Med; 2006 Dec; 48(6):660-5. PubMed ID: 17112930
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic significance of myocardial enzyme release after coronary interventions.
    Kelly D; Arora R
    Catheter Cardiovasc Interv; 1999 Mar; 46(3):292-302. PubMed ID: 10348125
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment.
    Chen WH; Lee PY; Ng W; Tse HF; Lau CP
    J Am Coll Cardiol; 2004 Mar; 43(6):1122-6. PubMed ID: 15028378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.
    Buller CE; Fu Y; Mahaffey KW; Todaro TG; Adams P; Westerhout CM; White HD; van 't Hof AW; Van de Werf FJ; Wagner GS; Granger CB; Armstrong PW
    Circulation; 2008 Sep; 118(13):1335-46. PubMed ID: 18779444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence, predictors, and clinical significance of troponin-I elevation without creatine kinase elevation following percutaneous coronary interventions.
    Natarajan MK; Kreatsoulas C; Velianou JL; Mehta SR; Pericak D; Goodhart DM
    Am J Cardiol; 2004 Mar; 93(6):750-3. PubMed ID: 15019884
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Percutaneous coronary intervention in the context of systemic inflammation: more injury and worse outcome.
    Saadeddin SM; Habbab MA
    Med Sci Monit; 2003 Aug; 9(8):RA193-7. PubMed ID: 12942045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measuring aspirin resistance, clopidogrel responsiveness, and postprocedural markers of myonecrosis in patients undergoing percutaneous coronary intervention.
    Buch AN; Singh S; Roy P; Javaid A; Smith KA; George CE; Pichard AD; Satler LF; Kent KM; Suddath WO; Waksman R
    Am J Cardiol; 2007 Jun; 99(11):1518-22. PubMed ID: 17531573
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myocardial infarction after percutaneous coronary intervention: a meta-analysis of troponin elevation applying the new universal definition.
    Testa L; Van Gaal WJ; Biondi Zoccai GG; Agostoni P; Latini RA; Bedogni F; Porto I; Banning AP
    QJM; 2009 Jun; 102(6):369-78. PubMed ID: 19286891
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Usefulness of peak troponin-T to predict infarct size and long-term outcome in patients with first acute myocardial infarction after primary percutaneous coronary intervention.
    Hassan AK; Bergheanu SC; Hasan-Ali H; Liem SS; van der Laarse A; Wolterbeek R; Atsma DE; Schalij MJ; Jukema JW
    Am J Cardiol; 2009 Mar; 103(6):779-84. PubMed ID: 19268731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial.
    Patti G; Pasceri V; Colonna G; Miglionico M; Fischetti D; Sardella G; Montinaro A; Di Sciascio G
    J Am Coll Cardiol; 2007 Mar; 49(12):1272-8. PubMed ID: 17394957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gender differences in the outcome of cardiac interventions.
    Tillmanns H; Waas W; Voss R; Grempels E; Hölschermann H; Haberbosch W; Waldecker B
    Herz; 2005 Aug; 30(5):375-89. PubMed ID: 16132240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.